|
{{date("d M, Y", strtotime($date) )}} |
{{date("h:iA", strtotime($session->dates->start[$i]) )}}-{{date("h:iA", strtotime($session->dates->end[$i]) )}} |
{{$session->venue}} |
Supported By
|
BURDEN OF OBSTRUCTIVE
|
|
India leads the world in the prevalence of Chronic Obstructive
Pulmonary Disease, ranks second only to China in deaths due to COPD
and is fast overtaking. With 37.8 million asthmatics, India contributes 11.16% to the prevalence of asthma globally. However, an alarming fact is that 43.6% of all global deaths due to asthma occur in India. Most of these deaths, which are largely avoidable, occur in adults which means that we are not doing enough to treat our cases of Asthma appropriately. The focus of practice for physicians in India today is cardio-metabolic, neurology or endocrine and understandably so. However at 83.8 million, the combined burden of Asthma and COPD in our country is far more than the burden of ischemic heart diseases or diabetes (16.5 and 67.8 million respectively)*. Moreover, COPD is a common co-morbid with cardiac diseases and it is important to identify it and manage it correctly for better patient outcomes. It has been documented that the CV disease outcomes improve if the COPD is treated appropriately. Thus,an adequate holistic approach to patients is the need of the day today. *Source: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 20168797 iResursSeamleIUnred Stares: Instrure for healinMeinesandievaluation (HME), 2018. Avallable from http:/gnax.nealthdata.ora/gbd-results-tool. |
ABOUT ROAD |
|
Refresher course on Obstructive Airways Diseases (ROAD) which was
initiated by the Chest Research Foundation (CRF), Pune has been helping physicians understand the nuances of diagnosis and management of Obstructive Airways Disease (ODs) since 2004. More than 120 ROAD programmes conducted since its inception have helped more than 6000 doctors understand the correct practices in Obstructive Airways Diseases. ROAD not only updates about the latest guidelines in asthma and COPD but the clinical expertise and pearls from the faculty making it a unique educational experience for practical implementation in the clinics and helps physicians add a differential to their practice for better patient outcomes. The ROAD is now being taken ahead by the Chest Research and Training Private Limited (CREST), Pune in an electronic format. Preceded by 04 videos on the clinical implications of the burden, risk factors and pathogenesis of Asthma and COPD, ROAD will also give physicians an opportunity to interact with the expert faculty via an online platform on two consecutive days over about 2 and a ½ hours sessions conveniently timed on a weekend. ROAD will also give physicians an opportunity to discuss their own challenging cases with experts as well as learn from cases presented by their peers in the "Bring your challenging cases to the forum' session which will be planned a month after the ROAD sessions. To summarise the new -ROAD assures:
|
Agenda |
Date : {{date("d M, Y", strtotime($date) )}} |
Time: {{date("h:iA", strtotime($session->dates->start[$i]) )}}-{{date("h:iA", strtotime($session->dates->end[$i]) )}} |
Venue : {{$session->venue}} |
| Session | Duration | Speaker |
|---|---|---|
| {{$agenda->title}} | {{$agenda->duration}} | {{$agenda->speaker}} |
| Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip |
Faculty |
|
|
{{$faculty->name}}{!!nl2br($faculty->description)!!} |
BRIEF OVERVIEW OF CREST |
|
In service of Respiratory Research and Health |
|
Regd. Address: 1" Floor FAITH Centre, Survey No. 232,
|
Dr. Sundeep SalviMD, DNB, PhD (UK), FCCP (USA), FICS, Hon FRCP (Lon)Chairman and Directer Chest Research |
Chest Research and Training Pvt. Ltd. (CREST) is a Private Limited Company based in Pune founded by Dr.Sundeed Salvi and his experienced team from Chest Research Foundation. CREST is driven by the mission of research, education and innovation in the field of respiratory medicine with the intention of improving respiratory healthcare and health with a special focus on Obstructive Airways Diseases |